Showing results (1941-1950 of 2,003) with videos related to

Sort By:
Pageof 201
Cancer Research|March 31, 2025
The Prolonged Half-Life of the p53 Missense Variant R248Q Promotes Accumulation and Heterotetramer Formation with Wild-Type p53 to Exert the Dominant-Negative EffectNancy Klemm, Roman R Schimmer, Nils K Konrad, et al.
JCI Insight|October 22, 2020
Hydroxychloroquine prophylaxis and treatment is ineffective in macaque and hamster SARS-CoV-2 disease modelsKyle Rosenke, Michael A Jarvis, Friederike Feldmann, et al.
Molecular Biology and Evolution|January 6, 2017
Phylogenetic Tools for Generalized HIV-1 Epidemics: Findings from the PANGEA-HIV Methods ComparisonOliver Ratmann, Emma B Hodcroft, Michael Pickles, et al.
The International Journal of Neuropsychopharmacology|January 6, 2010
Preclinical characterization of BRL 44408: antidepressant- and analgesic-like activity through selective alpha2A-adrenoceptor antagonismJason M Dwyer, Brian J Platt, Stacey J Sukoff Rizzo, et al.
Science (New York, N.Y.)|August 10, 2019
A dominant-negative effect drives selection of TP53 missense mutations in myeloid malignanciesSteffen Boettcher, Peter G Miller, Rohan Sharma, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|June 8, 2001
Double-blind, placebo-controlled study of amantadine hydrochloride in the treatment of children with autistic disorderB H King, D M Wright, B L Handen, et al.
The Journal of Experimental Medicine|July 28, 2020
Loss of decay-accelerating factor triggers podocyte injury and glomerulosclerosisAndrea Angeletti, Chiara Cantarelli, Astgik Petrosyan, et al.
British Journal of Pharmacology|July 2, 2010
WAY-318068: a novel, potent and selective noradrenaline re-uptake inhibitor with activity in rodent models of pain and depressionG T Whiteside, J M Dwyer, J E Harrison, et al.
JCPP Advances|March 15, 2024
Measurement bias in caregiver-report of early childhood behavior problems across demographic factors in an ECHO-wide diverse sampleShuting Zheng, Maxwell Mansolf, Monica McGrath, et al.
The Journal of Investigative Dermatology|October 30, 2009
Pediatric mastocytosis is a clonal disease associated with D816V and other activating c-KIT mutationsChristine Bodemer, Olivier Hermine, Fabienne Palmérini, et al.
Pageof 201